BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 25477377)

  • 1. Hepatic AQP9 expression in male rats is reduced in response to PPARα agonist treatment.
    Lebeck J; Cheema MU; Skowronski MT; Nielsen S; Praetorius J
    Am J Physiol Gastrointest Liver Physiol; 2015 Feb; 308(3):G198-205. PubMed ID: 25477377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen prevents increased hepatic aquaporin-9 expression and glycerol uptake during starvation.
    Lebeck J; Gena P; O'Neill H; Skowronski MT; Lund S; Calamita G; Praetorius J
    Am J Physiol Gastrointest Liver Physiol; 2012 Feb; 302(3):G365-74. PubMed ID: 22114114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-6 cooperates with peroxisome proliferator-activated receptor-α-ligands to induce liver fatty acid binding protein (LFABP) up-regulation.
    Vida M; Serrano A; Romero-Cuevas M; Pavón FJ; González-Rodriguez A; Gavito AL; Cuesta AL; Valverde AM; Rodríguez de Fonseca F; Baixeras E
    Liver Int; 2013 Aug; 33(7):1019-28. PubMed ID: 23534555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential gene expression in mouse primary hepatocytes exposed to the peroxisome proliferator-activated receptor alpha agonists.
    Guo L; Fang H; Collins J; Fan XH; Dial S; Wong A; Mehta K; Blann E; Shi L; Tong W; Dragan YP
    BMC Bioinformatics; 2006 Sep; 7 Suppl 2(Suppl 2):S18. PubMed ID: 17118139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biophysical assessment of aquaporin-9 as principal facilitative pathway in mouse liver import of glucogenetic glycerol.
    Calamita G; Gena P; Ferri D; Rosito A; Rojek A; Nielsen S; Marinelli RA; Frühbeck G; Svelto M
    Biol Cell; 2012 Jun; 104(6):342-51. PubMed ID: 22316404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defective glycerol metabolism in aquaporin 9 (AQP9) knockout mice.
    Rojek AM; Skowronski MT; Füchtbauer EM; Füchtbauer AC; Fenton RA; Agre P; Frøkiaer J; Nielsen S
    Proc Natl Acad Sci U S A; 2007 Feb; 104(9):3609-14. PubMed ID: 17360690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coordinated regulation of fat-specific and liver-specific glycerol channels, aquaporin adipose and aquaporin 9.
    Kuriyama H; Shimomura I; Kishida K; Kondo H; Furuyama N; Nishizawa H; Maeda N; Matsuda M; Nagaretani H; Kihara S; Nakamura T; Tochino Y; Funahashi T; Matsuzawa Y
    Diabetes; 2002 Oct; 51(10):2915-21. PubMed ID: 12351427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered expression and distribution of aquaporin-9 in the liver of rat with obstructive extrahepatic cholestasis.
    Calamita G; Ferri D; Gena P; Carreras FI; Liquori GE; Portincasa P; Marinelli RA; Svelto M
    Am J Physiol Gastrointest Liver Physiol; 2008 Oct; 295(4):G682-90. PubMed ID: 18669624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beyond lipids, pharmacological PPARalpha activation has important effects on amino acid metabolism as studied in the rat.
    Sheikh K; Camejo G; Lanne B; Halvarsson T; Landergren MR; Oakes ND
    Am J Physiol Endocrinol Metab; 2007 Apr; 292(4):E1157-65. PubMed ID: 17164430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic peroxisome proliferator-activated receptor alpha mediates the major metabolic effects of Wy-14643.
    Li G; Brocker CN; Xie C; Yan T; Noguchi A; Krausz KW; Xiang R; Gonzalez FJ
    J Gastroenterol Hepatol; 2018 May; 33(5):1138-1145. PubMed ID: 29141109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peroxisome proliferator-activated receptor-α agonist, Wy 14,643, improves metabolic indices, steatosis and ballooning in diabetic mice with non-alcoholic steatohepatitis.
    Larter CZ; Yeh MM; Van Rooyen DM; Brooling J; Ghatora K; Farrell GC
    J Gastroenterol Hepatol; 2012 Feb; 27(2):341-50. PubMed ID: 21929649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma mannose-binding lectin is stimulated by PPARα in humans.
    Rakhshandehroo M; Stienstra R; de Wit NJ; Bragt MC; Haluzik M; Mensink RP; Müller M; Kersten S
    Am J Physiol Endocrinol Metab; 2012 Mar; 302(5):E595-602. PubMed ID: 22215653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PPARalpha is a key regulator of hepatic FGF21.
    Lundåsen T; Hunt MC; Nilsson LM; Sanyal S; Angelin B; Alexson SE; Rudling M
    Biochem Biophys Res Commun; 2007 Aug; 360(2):437-40. PubMed ID: 17601491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aquaglyceroporin AQP9: solute permeation and metabolic control of expression in liver.
    Carbrey JM; Gorelick-Feldman DA; Kozono D; Praetorius J; Nielsen S; Agre P
    Proc Natl Acad Sci U S A; 2003 Mar; 100(5):2945-50. PubMed ID: 12594337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced hepatic aquaporin-9 and glycerol permeability are related to insulin resistance in non-alcoholic fatty liver disease.
    Rodríguez A; Gena P; Méndez-Giménez L; Rosito A; Valentí V; Rotellar F; Sola I; Moncada R; Silva C; Svelto M; Salvador J; Calamita G; Frühbeck G
    Int J Obes (Lond); 2014 Sep; 38(9):1213-20. PubMed ID: 24418844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic impact of the glycerol channels AQP7 and AQP9 in adipose tissue and liver.
    Lebeck J
    J Mol Endocrinol; 2014 Apr; 52(2):R165-78. PubMed ID: 24463099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of intestinal peptide transporter 1 expression during fasting is mediated via peroxisome proliferator-activated receptor alpha.
    Shimakura J; Terada T; Saito H; Katsura T; Inui K
    Am J Physiol Gastrointest Liver Physiol; 2006 Nov; 291(5):G851-6. PubMed ID: 16751172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamical modeling of liver Aquaporin-9 expression and glycerol permeability in hepatic glucose metabolism.
    Gena P; Buono ND; D'Abbicco M; Mastrodonato M; Berardi M; Svelto M; Lopez L; Calamita G
    Eur J Cell Biol; 2017 Jan; 96(1):61-69. PubMed ID: 28049557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A role for PPARalpha in the control of SREBP activity and lipid synthesis in the liver.
    Knight BL; Hebbachi A; Hauton D; Brown AM; Wiggins D; Patel DD; Gibbons GF
    Biochem J; 2005 Jul; 389(Pt 2):413-21. PubMed ID: 15777286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peroxisome proliferator-activated receptor alpha activation induces unfavourable changes in fatty acid composition of myocardial phospholipids.
    Baranowski M; Blachnio-Zabielska A; Gorski J
    J Physiol Pharmacol; 2009 Jun; 60(2):13-20. PubMed ID: 19617640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.